Gambro decided to cease bloodline manufacturing in Medolla, Italy, in order to optimize its global bloodline manufacturing footprint. The company will outsource a number of the bloodline manufacturing activities currently performed at the site. In addition, the agreement details a number of investments in R&D, and monitor manufacturing including the development of the highly differentiated Artis bloodline cassette. The focus for Gambro’s Medolla plant over the next coming years will be to improve the competitiveness of the Artis Monitor System.
For further information please contact:
Maria Lundbäck, Director External and Web Communications, Gambro +46 705 136534
Biagio Oppi, PR & Communications Manager, Gambro Italia, +39 338 6352349